MedPath

Anesticaine Spinal

Brand Name: Anesticaine Spinal

Generic Name: Bupivacaine Hydrochloride

Active
Registration Number

DRP-11591

Dosage Form

Solution for Intrathecal Injection

Issuance Date

April 1, 2022

Expiry Date

April 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength5 mg/mL (0.5% w/v)
Packaging5 mL (4 mL net content) Type 1 colorless glass ampoule (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Local Anaesthetic
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bupivacaine HydrochlorideActive
Monograph: Bupivacaine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform